Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug Discovery

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1452679

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1452679

In Vitro Toxicology Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)

PUBLISHED:
PAGES: 170 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PPT Slides/PDF & Excel (Enterprise License)
USD 4995

Add to Cart

Description

Table of Contents

The latest report from Persistence Market Research reveals that the global in vitro toxicology testing market is experiencing substantial growth, driven by a surge in research and development activities necessitating in vitro testing. The ban on animal testing, coupled with growing environmental concerns, has further propelled market expansion. Global In Vitro Toxicology Testing Market 2024-2031, the report forecasts a robust Compound Annual Growth Rate (CAGR) and highlights key trends shaping the industry landscape.

Rise in Demand for In Vitro Testing

In vitro toxicology testing plays a pivotal role in identifying harmful chemicals and toxins in various products, including agricultural chemicals, cosmetics, drugs, and food additives. The process aids in early detection of toxicity, ensuring safety in drug development, and assessing the potency of chemicals. With an increasing emphasis on product safety and regulatory compliance, the demand for in vitro testing services is on the rise.

Market Projections

According to Fairfield Market Research, the global in vitro toxicology testing market is projected to reach approximately US$ 11.2 billion in 2024, exhibiting a robust CAGR during the forecast period. North America is anticipated to dominate the market in terms of revenue, maintaining its lead throughout the assessment period. The region's market growth is driven by stringent regulations, technological advancements, and heightened awareness regarding environmental protection.

Assays Segment: Driving Market Growth

The assays segment is anticipated to have a considerable impact on market growth, maintaining a significant share within the product and services segment. Advancements in assay technologies and their greater adoption in drug development processes are driving the segment's growth trajectory, despite a moderate compound annual growth rate.

Cellular Assays Method Type: A Key Contributor

Fairfield Market Research predicts that the cellular assays method type segment will exceed the market value projected for 2024. This segment is poised to hold nearly half of the revenue share within the method segment initially. However, it is expected to witness a marginal decrease in market share in the foreseeable future, influenced by evolving market dynamics and emerging technologies.

Competition Analysis

The report profiles several key players expected to drive the expansion of the global in vitro toxicology testing market through 2031. These include:

  • SGS S.A.
  • Bio-Rad Laboratories, Inc.
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific SE
  • GE Healthcare Inc.
  • Merck KGaA
  • Promega Corporation
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc.
  • Cyprotex PLC

Market Segmentation:

Product & Services

  • Assays
  • Services
  • Reagents & Labware

Method

  • Cellular Assays
  • Biochemical Assays
  • EX Vivo Models

Industry

  • Pharmaceutical and Biopharmaceutical Industry
  • Cosmetics and Household Products Industry
  • Food Industry
  • Chemical Industry

Technology

  • Cell Culture Technologies
  • High-Throughput Technologies
  • Cellular Imaging Technologies
  • Toxicogenomics

Region

  • North America
  • Latin America
  • Europe
  • Japan
  • Asia Pacific excluding Japan
  • Middle East and Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global In Vitro Toxicology Testing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global In Vitro Toxicology Testing Market Outlook, 2018 - 2031

  • 3.1. Global In Vitro Toxicology Testing Market Outlook, by Product & Services, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Assays
      • 3.1.1.2. Services
      • 3.1.1.3. Reagents & Labware
  • 3.2. Global In Vitro Toxicology Testing Market Outlook, by Method, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Cellular Assays
      • 3.2.1.2. Biochemical Assays
      • 3.2.1.3. EX Vivo Models
  • 3.3. Global In Vitro Toxicology Testing Market Outlook, by Industry, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Pharmaceutical and Biopharmaceutical Industry
      • 3.3.1.2. Cosmetics and Household Products Industry
      • 3.3.1.3. Food Industry
      • 3.3.1.4. Chemical Industry
  • 3.4. Global In Vitro Toxicology Testing Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Cell Culture Technologies
      • 3.4.1.2. High-Throughput Technologies
      • 3.4.1.3. Cellular Imaging Technologies
      • 3.4.1.4. Toxicogenomics
  • 3.5. Global In Vitro Toxicology Testing Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America In Vitro Toxicology Testing Market Outlook, 2018 - 2031

  • 4.1. North America In Vitro Toxicology Testing Market Outlook, by Product & Services, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Assays
      • 4.1.1.2. Services
      • 4.1.1.3. Reagents & Labware
  • 4.2. North America In Vitro Toxicology Testing Market Outlook, by Method, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Cellular Assays
      • 4.2.1.2. Biochemical Assays
      • 4.2.1.3. EX Vivo Models
  • 4.3. North America In Vitro Toxicology Testing Market Outlook, by Industry, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Pharmaceutical and Biopharmaceutical Industry
      • 4.3.1.2. Cosmetics and Household Products Industry
      • 4.3.1.3. Food Industry
      • 4.3.1.4. Chemical Industry
  • 4.4. North America In Vitro Toxicology Testing Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Cell Culture Technologies
      • 4.4.1.2. High-Throughput Technologies
      • 4.4.1.3. Cellular Imaging Technologies
      • 4.4.1.4. Toxicogenomics
  • 4.5. North America In Vitro Toxicology Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 4.5.1.2. U.S. In Vitro Toxicology Testing Market by Method, Value (US$ Bn), 2018 - 2031
      • 4.5.1.3. U.S. In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 4.5.1.4. U.S. In Vitro Toxicology Testing Market by Technology, Value (US$ Bn), 2018 - 2031
      • 4.5.1.5. Canada In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 4.5.1.6. Canada In Vitro Toxicology Testing Market by Method, Value (US$ Bn), 2018 - 2031
      • 4.5.1.7. Canada In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 4.5.1.8. Canada In Vitro Toxicology Testing Market by Technology, Value (US$Bn), 2018 - 2031
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe In Vitro Toxicology Testing Market Outlook, 2018 - 2031

  • 5.1. Europe In Vitro Toxicology Testing Market Outlook, by Product & Services, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Assays
      • 5.1.1.2. Services
      • 5.1.1.3. Reagents & Labware
  • 5.2. Europe In Vitro Toxicology Testing Market Outlook, by Method, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Cellular Assays
      • 5.2.1.2. Biochemical Assays
      • 5.2.1.3. EX Vivo Models
  • 5.3. Europe In Vitro Toxicology Testing Market Outlook, by Industry, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Pharmaceutical and Biopharmaceutical Industry
      • 5.3.1.2. Cosmetics and Household Products Industry
      • 5.3.1.3. Food Industry
      • 5.3.1.4. Chemical Industry
  • 5.4. Europe In Vitro Toxicology Testing Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Cell Culture Technologies
      • 5.4.1.2. High-Throughput Technologies
      • 5.4.1.3. Cellular Imaging Technologies
      • 5.4.1.4. Toxicogenomics
  • 5.5. Europe In Vitro Toxicology Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 5.5.1.2. Germany In Vitro Toxicology Testing Market by Method, Value (US$Bn), 2018 - 2031
      • 5.5.1.3. Germany In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 5.5.1.4. Germany In Vitro Toxicology Testing Market by Technology, Value (US$ Bn), 2018 - 2031
      • 5.5.1.5. U.K. In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 5.5.1.6. U.K. In Vitro Toxicology Testing Market by Method, Value (US$ Bn), 2018 - 2031
      • 5.5.1.7. U.K. In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 5.5.1.8. U.K. In Vitro Toxicology Testing Market by Technology, Value (US$ Bn), 2018 - 2031
      • 5.5.1.9. France In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 5.5.1.10. France In Vitro Toxicology Testing Market by Method, Value (US$ Bn), 2018 - 2031
      • 5.5.1.11. France In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 5.5.1.12. France In Vitro Toxicology Testing Market by Technology, Value (US$ Bn), 2018 - 2031
      • 5.5.1.13. Italy In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 5.5.1.14. Italy In Vitro Toxicology Testing Market by Method, Value (US$ Bn), 2018 - 2031
      • 5.5.1.15. Italy In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 5.5.1.16. Italy In Vitro Toxicology Testing Market by Technology, Value (US$ Bn), 2018 - 2031
      • 5.5.1.17. Turkey In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 5.5.1.18. Turkey In Vitro Toxicology Testing Market by Method, Value (US$Bn), 2018 - 2031
      • 5.5.1.19. Turkey In Vitro Toxicology Testing Market by Industry, Value (US$Bn), 2018 - 2031
      • 5.5.1.20. Turkey In Vitro Toxicology Testing Market by Technology, Value (US$ Bn), 2018 - 2031
      • 5.5.1.21. Russia In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 5.5.1.22. Russia In Vitro Toxicology Testing Market by Method, Value (US$ Bn), 2018 - 2031
      • 5.5.1.23. Russia In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 5.5.1.24. Russia In Vitro Toxicology Testing Market by Technology, Value (US$ Bn), 2018 - 2031
      • 5.5.1.25. Rest of Europe In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 5.5.1.26. Rest of Europe In Vitro Toxicology Testing Market by Method, Value (US$ Bn), 2018 - 2031
      • 5.5.1.27. Rest of Europe In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 5.5.1.28. Rest of Europe In Vitro Toxicology Testing Market by Technology, Value (US$ Bn), 2018 - 2031
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific In Vitro Toxicology Testing Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific In Vitro Toxicology Testing Market Outlook, by Product & Services, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Assays
      • 6.1.1.2. Services
      • 6.1.1.3. Reagents & Labware
  • 6.2. Asia Pacific In Vitro Toxicology Testing Market Outlook, by Method, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Cellular Assays
      • 6.2.1.2. Biochemical Assays
      • 6.2.1.3. EX Vivo Models
  • 6.3. Asia Pacific In Vitro Toxicology Testing Market Outlook, by Industry, Value (US$Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Pharmaceutical and Biopharmaceutical Industry
      • 6.3.1.2. Cosmetics and Household Products Industry
      • 6.3.1.3. Food Industry
      • 6.3.1.4. Chemical Industry
  • 6.4. Asia Pacific In Vitro Toxicology Testing Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Cell Culture Technologies
      • 6.4.1.2. High-Throughput Technologies
      • 6.4.1.3. Cellular Imaging Technologies
      • 6.4.1.4. Toxicogenomics
  • 6.5. Asia Pacific In Vitro Toxicology Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. China In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 6.5.1.2. China In Vitro Toxicology Testing Market by Method, Value (US$ Bn), 2018 - 2031
      • 6.5.1.3. China In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 6.5.1.4. China In Vitro Toxicology Testing Market by Technology, Value (US$ Bn), 2018 - 2031
      • 6.5.1.5. Japan In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 6.5.1.6. Japan In Vitro Toxicology Testing Market by Method, Value (US$ Bn), 2018 - 2031
      • 6.5.1.7. Japan In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 6.5.1.8. Japan In Vitro Toxicology Testing Market by Technology, Value (US$Bn), 2018 - 2031
      • 6.5.1.9. South Korea In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 6.5.1.10. South Korea In Vitro Toxicology Testing Market by Method, Value (US$ Bn), 2018 - 2031
      • 6.5.1.11. South Korea In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 6.5.1.12. South Korea In Vitro Toxicology Testing Market by Technology, Value (US$ Bn), 2018 - 2031
      • 6.5.1.13. India In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 6.5.1.14. India In Vitro Toxicology Testing Market by Method, Value (US$ Bn), 2018 - 2031
      • 6.5.1.15. India In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 6.5.1.16. India In Vitro Toxicology Testing Market by Technology, Value (US$ Bn), 2018 - 2031
      • 6.5.1.17. Southeast Asia In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 6.5.1.18. Southeast Asia In Vitro Toxicology Testing Market by Method, Value (US$ Bn), 2018 - 2031
      • 6.5.1.19. Southeast Asia In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 6.5.1.20. Southeast Asia In Vitro Toxicology Testing Market by Technology, Value (US$ Bn), 2018 - 2031
      • 6.5.1.21. Rest of Asia Pacific In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 6.5.1.22. Rest of Asia Pacific In Vitro Toxicology Testing Market by Method, Value (US$ Bn), 2018 - 2031
      • 6.5.1.23. Rest of Asia Pacific In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 6.5.1.24. Rest of Asia Pacific In Vitro Toxicology Testing Market by Technology, Value (US$ Bn), 2018 - 2031
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America In Vitro Toxicology Testing Market Outlook, 2018 - 2031

  • 7.1. Latin America In Vitro Toxicology Testing Market Outlook, by Product & Services, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Assays
      • 7.1.1.2. Services
      • 7.1.1.3. Reagents & Labware
  • 7.2. Latin America In Vitro Toxicology Testing Market Outlook, by Method, Value (US$ Bn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Cellular Assays
      • 7.2.1.2. Biochemical Assays
      • 7.2.1.3. EX Vivo Models
  • 7.3. Latin America In Vitro Toxicology Testing Market Outlook, by Industry, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Pharmaceutical and Biopharmaceutical Industry
      • 7.3.1.2. Cosmetics and Household Products Industry
      • 7.3.1.3. Food Industry
      • 7.3.1.4. Chemical Industry
  • 7.4. Latin America In Vitro Toxicology Testing Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Cell Culture Technologies
      • 7.4.1.2. High-Throughput Technologies
      • 7.4.1.3. Cellular Imaging Technologies
      • 7.4.1.4. Toxicogenomics
  • 7.5. Latin America In Vitro Toxicology Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 7.5.1.2. Brazil In Vitro Toxicology Testing Market by Method, Value (US$ Bn), 2018 - 2031
      • 7.5.1.3. Brazil In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 7.5.1.4. Brazil In Vitro Toxicology Testing Market by Technology, Value (US$ Bn), 2018 - 2031
      • 7.5.1.5. Mexico In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 7.5.1.6. Mexico In Vitro Toxicology Testing Market by Method, Value (US$ Bn), 2018 - 2031
      • 7.5.1.7. Mexico In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 7.5.1.8. Mexico In Vitro Toxicology Testing Market by Technology, Value (US$ Bn), 2018 - 2031
      • 7.5.1.9. Argentina In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 7.5.1.10. Argentina In Vitro Toxicology Testing Market by Method, Value (US$ Bn), 2018 - 2031
      • 7.5.1.11. Argentina In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 7.5.1.12. Argentina In Vitro Toxicology Testing Market by Technology, Value (US$ Bn), 2018 - 2031
      • 7.5.1.13. Rest of Latin America In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 7.5.1.14. Rest of Latin America In Vitro Toxicology Testing Market by Method, Value (US$ Bn), 2018 - 2031
      • 7.5.1.15. Rest of Latin America In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 7.5.1.16. Rest of Latin America In Vitro Toxicology Testing Market by Technology, Value (US$ Bn), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa In Vitro Toxicology Testing Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa In Vitro Toxicology Testing Market Outlook, by Product & Services, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Assays
      • 8.1.1.2. Services
      • 8.1.1.3. Reagents & Labware
  • 8.2. Middle East & Africa In Vitro Toxicology Testing Market Outlook, by Method, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Cellular Assays
      • 8.2.1.2. Biochemical Assays
      • 8.2.1.3. EX Vivo Models
  • 8.3. Middle East & Africa In Vitro Toxicology Testing Market Outlook, by Industry, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Pharmaceutical and Biopharmaceutical Industry
      • 8.3.1.2. Cosmetics and Household Products Industry
      • 8.3.1.3. Food Industry
      • 8.3.1.4. Chemical Industry
  • 8.4. Middle East & Africa In Vitro Toxicology Testing Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Cell Culture Technologies
      • 8.4.1.2. High-Throughput Technologies
      • 8.4.1.3. Cellular Imaging Technologies
      • 8.4.1.4. Toxicogenomics
  • 8.5. Middle East & Africa In Vitro Toxicology Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 8.5.1.2. GCC In Vitro Toxicology Testing Market by Method, Value (US$ Bn), 2018 - 2031
      • 8.5.1.3. GCC In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 8.5.1.4. GCC In Vitro Toxicology Testing Market by Technology, Value (US$Bn), 2018 - 2031
      • 8.5.1.5. South Africa In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 8.5.1.6. South Africa In Vitro Toxicology Testing Market by Method, Value (US$ Bn), 2018 - 2031
      • 8.5.1.7. South Africa In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 8.5.1.8. South Africa In Vitro Toxicology Testing Market by Technology, Value (US$ Bn), 2018 - 2031
      • 8.5.1.9. Egypt In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 8.5.1.10. Egypt In Vitro Toxicology Testing Market by Method, Value (US$ Bn), 2018 - 2031
      • 8.5.1.11. Egypt In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 8.5.1.12. Egypt In Vitro Toxicology Testing Market by Technology, Value (US$ Bn), 2018 - 2031
      • 8.5.1.13. Nigeria In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 8.5.1.14. Nigeria In Vitro Toxicology Testing Market by Method, Value (US$ Bn), 2018 - 2031
      • 8.5.1.15. Nigeria In Vitro Toxicology Testing Market Method, Value (US$ Bn), 2018 - 2031
      • 8.5.1.16. Nigeria In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 8.5.1.17. Nigeria In Vitro Toxicology Testing Market by Technology, Value (US$ Bn), 2018 - 2031
      • 8.5.1.18. Rest of Middle East & Africa In Vitro Toxicology Testing Market by Product & Services, Value (US$ Bn), 2018 - 2031
      • 8.5.1.19. Rest of Middle East & Africa In Vitro Toxicology Testing Market by Method, Value (US$ Bn), 2018 - 2031
      • 8.5.1.20. Rest of Middle East & Africa In Vitro Toxicology Testing Market by Industry, Value (US$ Bn), 2018 - 2031
      • 8.5.1.21. Rest of Middle East & Africa In Vitro Toxicology Testing Market by Technology, Value (US$ Bn), 2018 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Product & Services vs Method Heatmap
  • 9.2. Manufacturer vs Method Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. SGS S.A.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product & Services Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Bio-Rad Laboratories, Inc.
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product & Services Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Charles River Laboratories International, Inc.
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product & Services Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. Eurofins Scientific Se
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product & Services Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. GE Healthcare
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product & Services Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. Merck KGaA
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product & Services Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Promega Corporation
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product & Services Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Qiagen N.V.
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product & Services Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. Thermo Fisher Scientific, Inc
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product & Services Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Cyprotex PLC
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product & Services Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Thermo Fisher Scientific, Inc.
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Product & Services Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. Abbott Laboratories
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Product & Services Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development
    • 9.5.13. Agilent Technologies
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Product & Services Portfolio
      • 9.5.13.3. Financial Overview
      • 9.5.13.4. Business Strategies and Development
    • 9.5.14. Covance
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Product & Services Portfolio
      • 9.5.14.3. Financial Overview
      • 9.5.14.4. Business Strategies and Development
    • 9.5.15. Laboratory Corporation of America Holdings
      • 9.5.15.1. Company Overview
      • 9.5.15.2. Product & Services Portfolio
      • 9.5.15.3. Financial Overview
      • 9.5.15.4. Business Strategies and Development
    • 9.5.16. Evotec S.E.
      • 9.5.16.1. Company Overview
      • 9.5.16.2. Product & Services Portfolio
      • 9.5.16.3. Financial Overview
      • 9.5.16.4. Business Strategies and Development
    • 9.5.17. Quest Diagnostics Incorporated
      • 9.5.17.1. Company Overview
      • 9.5.17.2. Product & Services Portfolio
      • 9.5.17.3. Financial Overview
      • 9.5.17.4. Business Strategies and Development
    • 9.5.18. Danaher Corporation
      • 9.5.18.1. Company Overview
      • 9.5.18.2. Product & Services Portfolio
      • 9.5.18.3. Financial Overview
      • 9.5.18.4. Business Strategies and Development
    • 9.5.19. Gentronix
      • 9.5.19.1. Company Overview
      • 9.5.19.2. Product & Services Portfolio
      • 9.5.19.3. Financial Overview
      • 9.5.19.4. Business Strategies and Development

10. Appendix

  • 10.1.Research Methodology
  • 10.2.Report Assumptions
  • 10.3.Acronyms and Abbreviations

List of Region/Countries

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Turkey
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!